Clinical Trial Update: COOL RCN: Cooling to Prevent Radiocontrast Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

The COOL RCN trial evaluating cooling to prevent radiocontrast nephropathy in Phase 2 and Phase 3 was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Kidney Failure
• Kidney Injury
• Renal Failure

Snippet

Sponsor: Radiant Medical | Conditions: Renal Failure, Kidney Failure | Phase 2, Phase 3 | Status: TERMINATED